Investigating the Role of Skin Autofluorescence in Gestational Diabetes Mellitus: A Systematic Review
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073022 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Bianca-Margareta Salmen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Diabetes, Gestational, Optical Imaging, Skin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) is a pregnancy-specific condition that can cause serious complications for both the mother and the fetus. Preventing these complications requires optimum glycemic control. Skin autofluorescence (SAF) is a non-invasive and innovative method that evaluates the levels of advanced glycation end products, markers of hyperglycemia, that could aid in the optimum management of GDM-complicated pregnancies. This systematic review aims to assess SAF’s potential utility in the prediction of short-term and long-term outcomes in GDM. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology, with the protocol identifier CRD42024559012, we used “(skin autofluorescence OR SAF) AND (gestational diabetes mellitus OR GDM)” as a search criterion on the PubMed, Scopus, and Web of Science databases. After a rigorous selection process, we included five articles, which evaluated SAF values and GDM, SAF and pregnancies complicated by diabetes mellitus, and SAF and macrosomia. GDM diagnosis varies due to the different approaches among the major guidelines, leading to variations in interpretation and diagnostic thresholds. Across studies, this variability contributes to inconsistent SAF values. As a standardized and objective marker, SAF could provide a uniform criterion, improving GDM management. Further research is needed to validate its clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Medical-Surgical and Complementary Sciences, Faculty of Medicine and Biological Sciences, "Stefan cel Mare" University, 720229 Suceava, Romania.
- Department of Diabetes, Nutrition and Metabolic Diseases, Consultmed Medical Centre, 700544 Iasi, Romania.
- Department of Biomedical Sciences, Faculty of Medical Bioengineering, University of Medicine and Pharmacy "Grigore T. Popa" Iasi, 700454 Iasi, Romania.
- Department of Obstetrics and Gynaecology, Filantropia Clinical Hospital, 011132 Bucharest, Romania.
- Department of Audiology, 'Maria Sklodowska Curie' Children's Emergency Clinical Hospital, 077120 Bucharest, Romania.
ORCID-Profile: Bianca-Margareta Salmen, Delia Reurean-Pintilei, Dan Trofin, Alexandra-Cristina Neagu, Roxana-Elena Bohiltea
Zitieren
APA
Salmen, B. M., Reurean-Pintilei, D., Trofin, D., Durdu, C. E., Neagu, A. C., & Bohiltea, R. E. (2025). Investigating the Role of Skin Autofluorescence in Gestational Diabetes Mellitus: A Systematic Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073022
Vancouver
Salmen BM, Reurean-Pintilei D, Trofin D, Durdu CE, Neagu AC, Bohiltea RE. Investigating the Role of Skin Autofluorescence in Gestational Diabetes Mellitus: A Systematic Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073022
BibTeX
@article{Salmen2025,
author = {Salmen, Bianca-Margareta and Reurean-Pintilei, Delia and Trofin, Dan and Durdu, Cristiana-Elena and Neagu, Alexandra-Cristina and Bohiltea, Roxana-Elena},
title = {Investigating the Role of Skin Autofluorescence in Gestational Diabetes Mellitus: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073022}
}
EUVIMED